跳至主要内容
临床试验/NCT01906957
NCT01906957终止不适用

Cerebral Oxygenation, Cardiac Output,Cognitive Function, and Exercise Training in Patients With Metabolic Syndrome, Coronary Heart Disease and Chronic Heart Failure.

Montreal Heart Institute2 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2013年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
入组人数
6
试验地点
2
主要终点
Cognitive function assessed by standard pen-paper battery test

研究概览

简要总结

The aim of study is to investigate the impact of two different training modalities (high intensity interval training (HIIT) versus moderate intensity continuous exercise training (MICET) on cognitive performance, cerebral oxygenation, cardiac output and physical fitness in older healthy adults, patients with metabolic syndrome, coronary heart disease and heart failure. The investigators hypothesized that HIIT modality will lead to a larger improvement in physical fitness (i.e. VO2peak), cardiovascular parameters (cardiac output and stroke volume) and cognitive performance at rest and during submaximal exercise. The primary endpoint will be the improvement in cognitive performance.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Elderly healthy subjects : with no MetS and no-documented CHD, both males and females, aged>60 years will be included in the study, should they provide written informed consent and have a sufficient initial physical and intellectual capacities allowing an independent daily living.
  • •Patients with metabolic syndrome and no-documented CHD, both males and females, aged > 18 years will be included in the study, should they provide written informed consent and have a sufficient initial physical and intellectual capacities allowing an independent daily living. MetS will be defined according to recent updated criteria: presence of at least three of five criteria, namely abdominal obesity (waist circumference cut-off depending on the recently published ethnic-based variations, triglycerides > 1.70 mmol/l, decreased HDL-cholesterol (< 1.0 mmol/l in men and < 1.3 mmol/l in women), systolic blood pressure > 130 mmHg or diastolic blood pressure > 85 mmHg, and FPG > 5.6 mmol/l.
  • •CHD patients, both males and females, aged > 18 years will be included in the study, should they provide written informed consent and have a sufficient initial physical and intellectual capacities allowing an independent daily living. Moreover, they must have documented CHD (prior myocardial infarction, prior coronary angiography or angioplasty, or documented myocardial ischemia on myocardial scintigraphy).
  • •Patients with documented stable chronic heart failure will be recruited if they show the following inclusion criteria:
  • •≥18 years
  • •Left ventricular ejection fraction (LVEF) <40% (measured within 6 months of their enrolment by MUGA Scan, echo or radiological ventriculography)
  • •NYHA functional class I-III
  • •Optimal therapy at stable doses including a beta-blocker and an ACE inhibitor or ARA for at least 6 weeks prior to investigation (unless documented rationale for variation).
  • •Able to perform an symptom limited exercise test.
  • •Capacity and willingness to sign the informed consent form.

排除标准

  • •For healthy elderly subjects:
  • •age under 60 years
  • •lack of expressed written consent
  • •metabolic syndrome
  • •coronary heart disease
  • •chronic systolic heart failure
  • •resting left ventricular ejection fraction < 40 %
  • •symptomatic aortic stenosis
  • •chronic atrial fibrillation
  • •malignant exertional arrhythmias
  • •non-cardiopulmonary limitation to exercise (e.g: arthritis or claudication)
  • •severe exercise intolerance.
  • •For patients with metabolic syndrome:
  • •lack of expressed written consent
  • •coronary heart disease
  • •chronic systolic heart failure
  • •resting left ventricular ejection fraction < 40 %
  • •symptomatic aortic stenosis
  • •chronic atrial fibrillation
  • •malignant exertional arrhythmias
  • •non-cardiopulmonary limitation to exercise (e.g: arthritis or claudication)
  • •severe exercise intolerance.
  • •For patients with CHD
  • •lack of expressed written consent
  • •recent acute coronary event (< 3 months)
  • •chronic systolic heart failure
  • •resting left ventricular ejection fraction < 40 %
  • •symptomatic aortic stenosis
  • •severe non-revascularize coronary disease including left main coronary stenosis
  • •patient awaiting coronary artery bypass surgery
  • •chronic atrial fibrillation
  • •presence of permanent ventricular pacemaker
  • •malignant exertional arrhythmias
  • •non-cardiopulmonary limitation to exercise (e.g: arthritis or claudication)
  • •severe exercise intolerance.
  • •For CHF patients:
  • •Any relative or absolute contraindications to exercise training among patients with stable chronic heart failure according to current recommendations (Working Group on Cardiac Rehabilitation 2001)
  • •Fixed-rate pacemaker or ICD devices with heart rate limits set lower than the exercise training target heart rate.
  • •Major cardiovascular event of procedure within the 3 months preceding enrolment in the study.
  • •Atrial fibrillation
  • •Heart failure secondary to significant uncorrected primary valvular disease (except for mitral regurgitation secondary to LV dysfunction)
  • •Heart failure secondary to congenital heart disease or obstructive cardiomyopathy.

研究组 & 干预措施

Elderly healthy subjects

Experimental

Randomization into :

  1. high intensity interval training (HIIT)(n=20)

or 2. moderate intensity intensity continuous exercise (n=20)

干预措施: moderate intensity continuous exercise training (Other)

Elderly healthy subjects

Experimental

Randomization into :

  1. high intensity interval training (HIIT)(n=20)

or 2. moderate intensity intensity continuous exercise (n=20)

干预措施: high intensity interval training (HIIT) (Other)

Patients with metabolic syndrome

Experimental

Randomization into :

  1. high intensity interval training (HIIT)(n=20)

or 2. moderate intensity intensity continuous exercise (n=20)

干预措施: high intensity interval training (HIIT) (Other)

Patients with metabolic syndrome

Experimental

Randomization into :

  1. high intensity interval training (HIIT)(n=20)

or 2. moderate intensity intensity continuous exercise (n=20)

干预措施: moderate intensity continuous exercise training (Other)

coronary patients

Experimental

Randomization into :

  1. high intensity interval training (HIIT)(n=20)

or 2. moderate intensity intensity continuous exercise (n=20)

干预措施: high intensity interval training (HIIT) (Other)

coronary patients

Experimental

Randomization into :

  1. high intensity interval training (HIIT)(n=20)

or 2. moderate intensity intensity continuous exercise (n=20)

干预措施: moderate intensity continuous exercise training (Other)

heart failure patients

Experimental

Randomization into :

  1. high intensity interval training (HIIT)(n=20)

or 2. moderate intensity intensity continuous exercise (n=20)

干预措施: high intensity interval training (HIIT) (Other)

heart failure patients

Experimental

Randomization into :

  1. high intensity interval training (HIIT)(n=20)

or 2. moderate intensity intensity continuous exercise (n=20)

干预措施: moderate intensity continuous exercise training (Other)

结局指标

主要结局

Cognitive function assessed by standard pen-paper battery test

时间窗: At baseline and after 3 months

a) Digit Span (Forward and Backward) (short-term and working memory), b) Digit Symbol Substitution Test (attention \& processing speed), c) Trail making test, part A and B (mental flexibility), d) D-KEFS Color-Word Interference Stroop Test (selective attention and inhibition) and e) Rey Auditory Verbal Learning Test (long-term verbal memory).

次要结局

  • Maximal aerobic capacity (VO2max)(At baseline and after 3 months)

研究者

发起方
Montreal Heart Institute
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mathieu Gayda

P.hD

Montreal Heart Institute

研究点 (2)

Loading locations...

相似试验